Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marilyn Kwan and Lawrence Kushi.
Marilyn Kwan
Connection Strength
13.678
Lawrence Kushi
  1. Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study. Cancer. 2023 Aug 09.
    View in: PubMed
    Score: 0.900
  2. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat. 2016 08; 159(1):119-29.
    View in: PubMed
    Score: 0.552
  3. Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
    View in: PubMed
    Score: 0.444
  4. Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control. 2012 Sep; 23(9):1587-91.
    View in: PubMed
    Score: 0.418
  5. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.395
  6. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
    View in: PubMed
    Score: 0.371
  7. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.353
  8. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
    View in: PubMed
    Score: 0.313
  9. Diet quality and cardiometabolic health in breast cancer survivors: the Pathways Study. Breast Cancer Res Treat. 2025 Feb 01.
    View in: PubMed
    Score: 0.249
  10. Physical activity and incident cardiovascular disease in breast cancer survivors: the Pathways Study. JNCI Cancer Spectr. 2025 Jan 03; 9(1).
    View in: PubMed
    Score: 0.248
  11. Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
    View in: PubMed
    Score: 0.245
  12. Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
    View in: PubMed
    Score: 0.243
  13. The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Gu?rin in Treating Nonmuscle-Invasive Bladder Cancer. J Urol. 2024 Sep; 212(3):420-430.
    View in: PubMed
    Score: 0.238
  14. Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer. JAMA Netw Open. 2024 Mar 04; 7(3):e243345.
    View in: PubMed
    Score: 0.234
  15. Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study. JNCI Cancer Spectr. 2024 Feb 29; 8(2).
    View in: PubMed
    Score: 0.234
  16. Hypothetical interventions on diet quality and lifestyle factors to improve breast cancer survival: the Pathways Study. Cancer Epidemiol Biomarkers Prev. 2023 Sep 18.
    View in: PubMed
    Score: 0.227
  17. Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2023 07 05; 32(7):963-975.
    View in: PubMed
    Score: 0.223
  18. Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort. Urology. 2022 Dec 24.
    View in: PubMed
    Score: 0.215
  19. Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study. JAMA Netw Open. 2022 11 01; 5(11):e2244430.
    View in: PubMed
    Score: 0.213
  20. Reply to M.S. Ewer et al. J Clin Oncol. 2022 Jul 25; JCO2201353.
    View in: PubMed
    Score: 0.209
  21. Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Res Treat. 2022 Jun; 193(3):669-675.
    View in: PubMed
    Score: 0.205
  22. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
    View in: PubMed
    Score: 0.205
  23. UACA locus is associated with breast cancer chemoresistance and survival. NPJ Breast Cancer. 2022 Mar 23; 8(1):39.
    View in: PubMed
    Score: 0.204
  24. Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile. Cancer Causes Control. 2022 May; 33(5):711-726.
    View in: PubMed
    Score: 0.202
  25. Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 Jan 13; JCO2101738.
    View in: PubMed
    Score: 0.202
  26. Diet Quality and Breast Cancer Recurrence and Survival: The Pathways Study. JNCI Cancer Spectr. 2021 Apr; 5(2):pkab019.
    View in: PubMed
    Score: 0.190
  27. "I Had to Make Them Feel at Ease": Narrative Accounts of How Women With Breast Cancer Navigate Social Support. Qual Health Res. 2021 05; 31(6):1056-1068.
    View in: PubMed
    Score: 0.190
  28. The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort. Cancer Epidemiol Biomarkers Prev. 2021 May; 30(5):857-866.
    View in: PubMed
    Score: 0.190
  29. A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting. J Cancer Surviv. 2021 Feb 09.
    View in: PubMed
    Score: 0.189
  30. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study. Breast Cancer Res Treat. 2020 Feb; 180(1):187-195.
    View in: PubMed
    Score: 0.175
  31. Trends in Medical Imaging During Pregnancy in the United States and Ontario, Canada, 1996 to 2016. JAMA Netw Open. 2019 07 03; 2(7):e197249.
    View in: PubMed
    Score: 0.169
  32. The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
    View in: PubMed
    Score: 0.164
  33. Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System. J Pain Symptom Manage. 2019 Mar; 57(3):587-595.
    View in: PubMed
    Score: 0.162
  34. Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use. Urology. 2019 Feb; 124:107-112.
    View in: PubMed
    Score: 0.161
  35. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat. 2018 Aug; 170(3):623-631.
    View in: PubMed
    Score: 0.156
  36. Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions. Breast Cancer Res Treat. 2018 Aug; 170(3):593-603.
    View in: PubMed
    Score: 0.155
  37. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.152
  38. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.145
  39. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol. 2017 Mar 01; 3(3):351-357.
    View in: PubMed
    Score: 0.144
  40. Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat. 2017 02; 161(3):501-513.
    View in: PubMed
    Score: 0.142
  41. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. J Natl Cancer Inst. 2017 02; 109(2).
    View in: PubMed
    Score: 0.141
  42. Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer. 2015 Oct 14; 15:688.
    View in: PubMed
    Score: 0.131
  43. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.127
  44. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.126
  45. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.122
  46. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer. 2014 May 29; 14:382.
    View in: PubMed
    Score: 0.119
  47. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun; 139(2):515-27.
    View in: PubMed
    Score: 0.111
  48. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013 Jun; 22(6):1411-20.
    View in: PubMed
    Score: 0.105
  49. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.096
  50. Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat. 2011 Sep; 129(2):521-9.
    View in: PubMed
    Score: 0.096
  51. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.092
  52. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.092
  53. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
    View in: PubMed
    Score: 0.084
  54. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009 Oct; 117(3):653-65.
    View in: PubMed
    Score: 0.082
  55. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
    View in: PubMed
    Score: 0.082
  56. Lifestyle factors and survival in women with breast cancer. J Nutr. 2007 01; 137(1 Suppl):236S-242S.
    View in: PubMed
    Score: 0.071
  57. Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectr. 2025 Jan 28.
    View in: PubMed
    Score: 0.062
  58. Race and ethnicity and self-reported racial/ethnic discrimination in breast cancer patient interactions with providers in the Pathways Study. Breast Cancer Res Treat. 2024 Oct 05.
    View in: PubMed
    Score: 0.061
  59. Cancer Diagnosis During Pregnancy and Livebirth Outcomes in the Adolescent and Young Adult Horizon Study. J Womens Health (Larchmt). 2024 Sep 05.
    View in: PubMed
    Score: 0.061
  60. A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer. Breast Cancer Res Treat. 2024 Jul 08.
    View in: PubMed
    Score: 0.060
  61. Association between Neighborhood Stressors and Allostatic Load in Breast Cancer Survivors: The Pathways Study. Am J Epidemiol. 2024 Jun 18.
    View in: PubMed
    Score: 0.060
  62. Epidemiology of early vs. Late recurrence among women with Early-Stage estrogen Receptor-Positive breast cancer in the pathways study. J Natl Cancer Inst. 2024 Jun 06.
    View in: PubMed
    Score: 0.060
  63. Modifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study. Mol Nutr Food Res. 2024 Apr 06; e2400087.
    View in: PubMed
    Score: 0.059
  64. A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors. NPJ Breast Cancer. 2024 Jan 20; 10(1):9.
    View in: PubMed
    Score: 0.058
  65. Risk of adverse birth outcomes after adolescent and young adult cancer. JNCI Cancer Spectr. 2024 Jan 04; 8(1).
    View in: PubMed
    Score: 0.058
  66. Environmental and Occupational Exposures and Prognosis in Patients with Non-Muscle Invasive Bladder Cancer in the Be-Well Study. Am J Epidemiol. 2023 Dec 05.
    View in: PubMed
    Score: 0.057
  67. A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer Res Commun. 2023 06; 3(6):1104-1112.
    View in: PubMed
    Score: 0.056
  68. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023 Aug; 201(1):117-126.
    View in: PubMed
    Score: 0.056
  69. Caring for Children in Relation to Financial Hardship, Advance Care Planning, and Genetic Testing Among Adolescent and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2023 Jun 01.
    View in: PubMed
    Score: 0.055
  70. Development and testing of a polygenic risk score for breast cancer aggressiveness. NPJ Precis Oncol. 2023 May 15; 7(1):42.
    View in: PubMed
    Score: 0.055
  71. Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study. Cancer. 2023 08 01; 129(15):2395-2408.
    View in: PubMed
    Score: 0.055
  72. Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings from the Be-Well Study. Am J Clin Nutr. 2023 06; 117(6):1110-1120.
    View in: PubMed
    Score: 0.055
  73. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Res Sq. 2023 Mar 22.
    View in: PubMed
    Score: 0.055
  74. Pregnancy attempts among adolescent and young adult cancer survivors. Fertil Steril. 2022 Dec 17.
    View in: PubMed
    Score: 0.054
  75. Impact of Racial/Ethnic Discrimination on Quality of Life among Breast Cancer Survivors: The Pathways Study. Am J Epidemiol. 2022 Dec 01.
    View in: PubMed
    Score: 0.054
  76. Positive predictive value and sensitivity of ICD-9-CM codes for identifying pediatric leukemia. Pediatr Blood Cancer. 2022 Feb; 69(2):e29383.
    View in: PubMed
    Score: 0.050
  77. Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study. Nutrients. 2021 Sep 25; 13(10).
    View in: PubMed
    Score: 0.049
  78. Clustering of Social and Physical Pain Variables and Their Association With Mortality in Two Population-Based Cohorts. Psychosom Med. 2021 04 01; 83(3):228-238.
    View in: PubMed
    Score: 0.048
  79. Effects of cooking methods on total isothiocyanate yield from cruciferous vegetables. Food Sci Nutr. 2020 Oct; 8(10):5673-5682.
    View in: PubMed
    Score: 0.046
  80. Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study. J Cancer Surviv. 2020 06; 14(3):393-403.
    View in: PubMed
    Score: 0.044
  81. Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2020 Jan; 179(1):229-240.
    View in: PubMed
    Score: 0.043
  82. Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016. JAMA. 2019 09 03; 322(9):843-856.
    View in: PubMed
    Score: 0.043
  83. SeqSQC: A Bioconductor Package for Evaluating the Sample Quality of Next-generation Sequencing Data. Genomics Proteomics Bioinformatics. 2019 Apr 05.
    View in: PubMed
    Score: 0.042
  84. Early-onset triple-negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations. Cancer Med. 2019 Apr; 8(4):1845-1853.
    View in: PubMed
    Score: 0.041
  85. Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study. Clin Breast Cancer. 2019 Mar 06.
    View in: PubMed
    Score: 0.041
  86. Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1466-1469.
    View in: PubMed
    Score: 0.037
  87. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.036
  88. Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors. Breast Cancer Res Treat. 2017 04; 162(3):549-557.
    View in: PubMed
    Score: 0.036
  89. Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):505-515.
    View in: PubMed
    Score: 0.036
  90. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. JAMA Oncol. 2016 Sep 01; 2(9):1170-6.
    View in: PubMed
    Score: 0.035
  91. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.035
  92. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.034
  93. The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1207-13.
    View in: PubMed
    Score: 0.032
  94. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.029
  95. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
    View in: PubMed
    Score: 0.029
  96. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.029
  97. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 2012 Apr 15; 118(8):2048-58.
    View in: PubMed
    Score: 0.025
  98. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011 Apr; 126(2):529-37.
    View in: PubMed
    Score: 0.023
  99. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet. 2010 Jul 29; 6(7):e1001043.
    View in: PubMed
    Score: 0.023

© 2025 Kaiser Permanente